 |
|
|
| |
Dolutegravir Use During Pregnancy and Birth Outcomes: Data From the Antiretroviral Pregnancy Registry (APR)
|
| |
| |
Reported by Jules Levin
9th IAS Conference on HIV Science; July 23-26, 2017; Paris, France
Vani Vannappagari,1,2Jessica D. Albano,3Leigh Ragone,1Angela E. Scheuerle,4Hugh Tilson,2Taylor Cook,5Yuming Xue,6Mandy Bowen,7Nadja Vielot,2Harmony Garges8
1ViiV Healthcare, Epidemiology and Real World Evidence, Research Triangle Park, NC, USA; 2Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 3INC Research, Real World & Late Phase, Raleigh, NC, USA; 4University of Texas Southwestern Medical Center, Department of Pediatrics, Dallas, TX, USA; 5INC Research, Real World & Late Phase, Wilmington, NC, USA; 6INC Research, Biometrics, Raleigh, NC, USA; 7INC Research, Biometrics, Wilmington, NC, USA; 8ViiV Healthcare Global Medical Sciences, Research Triangle Park, NC, USA
|
| |
|
|
|
|
|
